Abstract
摘要
相似文献
1
[Not Available].
Rev Med Suisse. 2016 Apr 20;12(515):816.
2
Gaining medical momentum.
Nature. 2004 Jun 3;429(6991 Suppl):19-23. doi: 10.1038/429a19a.
3
What's fueling the biotech engine?
Nat Biotechnol. 2007 Oct;25(10):1097-104. doi: 10.1038/nbt1007-1097.
4
[From a crisis to another...Pharmaceutical industry--economics].
Rev Med Liege. 2009 Jan;64(1):3-5.
5
India's growing participation in global clinical trials.
Trends Pharmacol Sci. 2011 Jun;32(6):327-9. doi: 10.1016/j.tips.2011.02.017. Epub 2011 Apr 12.
6
A status report on neuroscience research, without grade inflation.
Ann Neurol. 2006 Dec;60(6):A9-11. doi: 10.1002/ana.21054.
7
America's other drug problem: how the drug industry distorts medicine and politics.
New Repub. 2002 Dec 16;227(25):27-41.
8
Job movements.
Nature. 2005 Feb 24;433(7028):901. doi: 10.1038/nj7028-901a.
9
Europe fiddles while innovation burns.
Nat Rev Drug Discov. 2005 Sep;4(9):704-5. doi: 10.1038/nrd1838.
10
Commercial interest waxes for IGF-1 blockers.
Nat Biotechnol. 2008 Jul;26(7):719-20. doi: 10.1038/nbt0708-719.
Zotero 插件